S’UIMIN inc.

Based in Japan, S’UIMIN inc. specializes in innovative sleep measurement services, offering advanced solutions to assess and improve sleep quality through technology-driven insights. Founded in 2017 in Tokyo, Japan, S’UIMIN inc. focuses on sleep measurement services.

The company has successfully completed 5 deals, with the latest being a Series B funding round of JPY 500. 000 mn raised in May 2022 from NAGASE & CO. , LTD. and Teikoku Tsushin Kogyo Co.

, Ltd. As of this round, the total amount raised by S’UIMIN is JPY 500. 000 mn, with a current company valuation of JPY 4,552. 941 mn.

S'UIMIN specializes in advanced sleep measurement services through its flagship product, InSomnograf. This service measures brainwaves to objectively assess sleep patterns, generating comprehensive reports analyzed using artificial intelligence. InSomnograf provides insights into sleep quality, allowing individuals and organizations to understand and improve their sleep health. This user-friendly service can be accessed from home, making hospital-level sleep analysis more accessible.

The primary clientele includes individual consumers seeking personal sleep improvement and corporations interested in health management solutions for employees in Japan and potential international markets. S'UIMIN generates revenue through structured business transactions, primarily focusing on subscription models and direct-to-consumer sales. Clients can access InSomnograf services through tailored health programs or individual assessments incorporated into corporate wellness initiatives. Revenue comes from the sale of sleep analysis reports, personalized improvement plans, and subscription services for ongoing sleep pattern monitoring.

Each offering is designed to enhance understanding of sleep health, contributing to the company's overall revenue stream. S’UIMIN aims to expand its product line and geographic reach. The company is developing upcoming products that leverage advanced sleep technology, with specific launch dates yet to be announced. Targeting expansion beyond Japan, S’UIMIN plans to enter new international markets, enhancing their global footprint.

The recent Series B funding round of JPY 500. 000 mn will be utilized to promote the integration of life science and technology, supporting the company's growth initiatives. Additionally, in May 2022, S’UIMIN raised venture funding from Kyowa Co. , Ltd.

to further bolster its market presence.